EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

High prevalence and immunophenotypic diversity of clonal T‑large granular lymphocytes in JAK2‑mutated myeloproliferative neoplasms

Weixia Zhuang, Lisha Lu, Li Jiang, Biyan Chen, Moufeng Wang

Annals of Hematology · 28.09.2026 · 105 (11)

DOI: 10.1007/s00277-026-07292-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Hematology, online erschienen am 28.09.2026. Verfasst von Weixia Zhuang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, the First Affiliated Hospital, Fujian Medical University, FuzhouFujian, 350004, China. Hauptthemen laut MEDLINE: Janus Kinase 2, Myeloproliferative Disorders, Mutation, T-Lymphocytes. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Joint Funds for the Innovation of Science and Technology,Fujian Province, Natural Science Foundation of Fujian Province, Fujian Education and Research Grants for Young and Middle-aged Teachers.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients with JAK2‑mutated MPN may develop clonal T‑cell expansions, but the prevalence, immunophenotypic spectrum, and association with other lymphoid clones remain poorly defined. Clonal T‑large granular lymphocyte (T‑LGL) expansions have been observed in myeloproliferative neoplasms (MPN), but systematic data comparing different MPN driver mutations are lacking. This retrospective study of 354 MPN patients (182 BCR::ABL⁺, 163 JAK2⁺, 9 CALR⁺) evaluated the prevalence and immunophenotypic features of clonal T‑LGL, and examined their co‑occurrence with monoclonal B cells and plasma cells. We retrospectively analyzed flow cytometry and molecular data from 354 consecutive MPN patients between January 2021 and April 2026. Clonal T‑LGL were identified by T-cell receptor beta chain constant region 1 (TRBC1) restriction ( > 85% or 85%) in 39.3% (11/28). CD5 downregulation/loss was observed in 57.1% (16/28) and CD7 downregulation/loss in 46.4% (13/28). CD56/CD57 positivity were 35.7% (10/28) and 78.6% (22/28), respectively. Notably, the majority of CD8⁺ T-LGL clones also expressed CD57, representing the predominant immunophenotype. In the JAK2⁺ group, 2 patients (7.1%) had concurrent monoclonal B cells. JAK2‑mutated MPN patients have a significantly higher prevalence of clonal T‑LGL (17.2%) compared with BCR::ABL⁺ MPN (3.3%) with diverse immunophenotypes, predominantly CD8⁺ with frequent CD57 expression and CD5/CD7 aberrancy. A small subset of JAK2⁺ T-LGL patients (2/28, 7.1%) had concurrent monoclonal B cells, no plasma cell clones were identified. Routine TRBC1‑based flow cytometric screening for T‑cell clonality is recommended in JAK2‑mutated MPN patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Janus Kinase 2Myeloproliferative DisordersMutationT-LymphocytesHumansFemaleMaleImmunophenotypingRetrospective StudiesMiddle AgedAgedAdultAged, 80 and overPrevalence

Stichwörter der Autor:innen

JAK2 mutationMyeloproliferative neoplasmsTRBC1T‑large granular lymphocytes

Substanzen

Janus Kinase 2JAK2 protein, human

Autor:innen und Institutionen

  • Department of Pharmacy, the First Affiliated Hospital, Fujian Medical University, FuzhouFujian, 350004, China.
  • National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, 350212, China.
  • State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sc…
  • Molecular Biology Laboratory, Tianjin Union Precision Medical Diagnostic Co., Ltd, Tianjin, 301617, China.
  • Clinical Laboratory, the First Affiliated Hospital, Fujian Medical University, FuzhouFujian, 350004, China.
  • Department of Pharmacy, Fujian Medical University Union Hospital, Fujian, 350001, China.

Förderung

  • Joint Funds for the Innovation of Science and Technology,Fujian Province
  • Natural Science Foundation of Fujian Province
  • Fujian Education and Research Grants for Young and Middle-aged Teachers

Zitieren

APA

Zhuang, W., Lu, L., Jiang, L., Chen, B., & Wang, M. (2026). High prevalence and immunophenotypic diversity of clonal T‑large granular lymphocytes in JAK2‑mutated myeloproliferative neoplasms. Annals of Hematology, 105(11). https://doi.org/10.1007/s00277-026-07292-7

Vancouver

Zhuang W, Lu L, Jiang L, Chen B, Wang M. High prevalence and immunophenotypic diversity of clonal T‑large granular lymphocytes in JAK2‑mutated myeloproliferative neoplasms. Annals of Hematology. 2026;105(11). doi:10.1007/s00277-026-07292-7

BibTeX
@article{Zhuang2026,
  author = {Zhuang, Weixia and Lu, Lisha and Jiang, Li and Chen, Biyan and Wang, Moufeng},
  title = {High prevalence and immunophenotypic diversity of clonal T‑large granular lymphocytes in JAK2‑mutated myeloproliferative neoplasms},
  journal = {Annals of Hematology},
  year = {2026},
  volume = {105},
  number = {11},
  doi = {10.1007/s00277-026-07292-7}
}
Kostenlos starten →